-
Novel proteinaceous infectious particles cause scrapie.
After infection and a prolonged incubation period, the scrapie agent causes a degenerative disease of the central nervous system in sheep and goats. Six lines of evidence including sensitivity to proteases demonstrate that this agent contains a protein that is required for infectivity. Although the scrapie agent is irreversibly inactivated by alkali, five procedures with more specificity for modifying nucleic acids failed to cause inactivation. The agent shows heterogeneity with respect to size, apparently a result of its hydrophobicity; the smallest form may have a molecular weight of 50,000 or less. Because the novel properties of the scrapie agent distinguish it from viruses, plasmids, and viroids, a new term "prion" is proposed to denote a small proteinaceous infectious particle which is resistant to inactivation by most procedures that modify nucleic acids. Knowledge of the scrapie agent structure may have significance for understanding the causes of several degenerative diseases.
PMID: 6801762 [PubMed - indexed for MEDLINE]
-
Cited by over 100 PubMed Central articles
-
Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay.
Karapetyan YE, Saá P, Mahal SP, Sferrazza GF, Sherman A, Salès N, Weissmann C, Lasmézas CI.
PLoS One. 2009 May 29; 4(5):e5730. Epub 2009 May 29.
[PLoS One. 2009]
-
Heterologous cross-seeding mimics cross-species prion conversion in a yeast model.
Vishveshwara N, Liebman SW.
BMC Biol. 2009 May 26; 7:26. Epub 2009 May 26.
[BMC Biol. 2009]
-
Chemical and biophysical insights into the propagation of prion strains.
Falsig J, Nilsson KP, Knowles TP, Aguzzi A.
HFSP J. 2008 Dec; 2(6):332-41. Epub 2008 Oct 13.
[HFSP J. 2008]
- » See all...